BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas Biotech Investing
Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125 Pharmaceutical Investing
Humanigen Signs Agreement With MD Anderson Cancer Center to Begin Research Investigating Lenzilumab as CAR-T Support Pharmaceutical Investing
Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA Pharmaceutical Investing
Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint Genetics Investing
G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer Biotech Investing
Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership Biotech Investing
Xanthic Biopharma Inc. Commends The U.S. Federal Government’s Promise To Protect States That Have Legalized Cannabis Cannabis Investing News
Canntab Therapeutics Announces Completion of Amalgamation with Telferscot Resources Cannabis Investing News
